INTERNATIONAL PATENT: SANOFI-AVENTIS U.S. LLC FILES APPLICATION FOR "USE OF ANTI-CD38 ANTIBODY IN THE TREATMENT OF NEW DIAGNOSED MULTIPLE MYELOMA"

GENEVA, June 19 -- SANOFI-AVENTIS U.S. LLC (55 Corporate DriveBridgewater, New Jersey 08807) filed a patent application (PCT/US2024/058743) for "USE OF ANTI-CD38 ANTIBODY IN THE TREATMENT OF NEW DIAGNOSED MULTIPLE MYELOMA" on Dec 05, 2024. With publication no. WO/2025/122791, the details related to the patent application was published on Jun 12, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): CORZO, Kathryn Penkus (c/o Sanofi, Patent Department450 Water StreetCambridge, Massachusetts 02141), OPREA, Ileana Corina (c/o Sanofi, Patent Department46 avenue de la Grande Armee75017 Paris)

Abstract...